Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-23-005416
Filing Date
2023-04-28
Accepted
2023-04-28 16:20:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA 14A mnpr_defa14a.htm DEFA14A 7425
2 mnpr_defa14aimg3.jpg GRAPHIC 186762
3 mnpr_defa14aimg4.jpg GRAPHIC 138400
  Complete submission text file 0001654954-23-005416.txt   456386
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39070 | Film No.: 23866617
SIC: 2834 Pharmaceutical Preparations